| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.097 | 0.5 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |